Celgene Corp (CELG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2019 | 06-2019 | 03-2019 | 12-2018 | 09-2018 | |
| Sales | 4,520,000 | 4,400,000 | 4,025,000 | 4,037,000 | 3,892,000 |
| Cost of Goods | 167,000 | 151,000 | 140,000 | 169,000 | 157,000 |
| Gross Profit | 4,353,000 | 4,249,000 | 3,885,000 | 3,868,000 | 3,735,000 |
| Operating Expenses | 2,089,000 | 2,138,000 | 2,175,000 | 2,061,000 | 2,055,000 |
| Operating Income | 2,264,000 | 2,111,000 | 1,710,000 | 1,807,000 | 1,680,000 |
| Interest Expense | 190,000 | 192,000 | 192,000 | 190,000 | 193,000 |
| Other Income | -157,000 | -98,000 | 296,000 | -500,000 | -109,000 |
| Pre-tax Income | 1,917,000 | 1,821,000 | 1,814,000 | 1,117,000 | 1,378,000 |
| Income Tax | 226,000 | 250,000 | 269,000 | 44,000 | 296,000 |
| Net Income Continuous | 1,691,000 | 1,571,000 | 1,545,000 | 1,073,000 | 1,082,000 |
| Net Income | $1,691,000 | $1,571,000 | $1,545,000 | $1,073,000 | $1,082,000 |
| EPS Basic Total Ops | 2.38 | 2.22 | 2.20 | 1.52 | 1.54 |
| EPS Basic Continuous Ops | 2.38 | 2.22 | 2.20 | 1.52 | 1.54 |
| EPS Diluted Total Ops | 2.32 | 2.16 | 2.14 | 1.48 | 1.50 |
| EPS Diluted Continuous Ops | 2.32 | 2.16 | 2.14 | 1.48 | 1.50 |
| EPS Diluted Before Non-Recurring Items | 2.75 | 2.61 | 2.28 | 2.20 | 2.03 |
| EBITDA(a) | $2,435,000 | $2,269,000 | $1,867,000 | $1,947,000 | $1,879,000 |